Exactech to Host Financial Analyst Meetings at AAOS, Present at Orthopaedics Financial Conference
Orthopaedic firm to highlight shoulder, hip and knee implant products at exhibit during American Academy of Orthopaedic Surgeons Annual Meeting Gainesville, Fla. -- March 3, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced it will host financial analyst meetings in conjunction with the company’s display for surgeons during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco March 5 through March 7.
Orthopaedic firm to highlight shoulder, hip and knee implant products at exhibit during American Academy of Orthopaedic Surgeons Annual Meeting
Gainesville, Fla. -- March 3, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced it will host financial analyst meetings in conjunction with the company’s display for surgeons during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco March 5 through March 7.
At AAOS Exactech will unveil a variety of new medical education technologies. An interactive animation guides surgeons through the Equinoxe® reverse shoulder system’s innovative surgical technique. A computer simulation program demonstrates the Novation® hip system’s excellent range-of-motion and a navigation laboratory provides hands-on experience and training in the latest computer-assisted surgical techniques. Live surgical videos highlight benefits of Exactech biologic materials and the InterSpace® bone cement.
New products and instrumentation including the Equinoxe® reverse shoulder, the Novation Crown Cup™ and Ceramic AHS™ acetabular systems, the Novation® Splined RDD hip stem, enhancements to the Optetrak® knee system, and a new bone cement mixing system will be demonstrated at product kiosks and in the exhibit’s two surgical skills workshops. Surgeons and other technical experts will be available to discuss the design rationales and clinical outcomes associated with Exactech products.
Prior to AAOS, Exactech will make a presentation to investment community analysts on March 4 at the Canaccord Adams’ Small-Cap Orthopedic Conference, also held in San Francisco. The conference features 40 private and public small cap orthopaedic companies. Exactech Chairman and CEO Dr. William Petty will deliver the presentation, which will be available via webcast at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2186580.
About the AAOS
Founded in 1933, The American Academy of Orthopaedic Surgeons is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world. Its continuing medical education activities include a world-renowned Annual Meeting, multiple CME courses held around the country and at the Orthopaedic Learning Center, and various medical and scientific publications and electronic media materials. For more information, visit http://www.aaos.org/education/anmeet/anmeet.asp.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and Australia, in addition to more than 25 countries in Europe, Asia and Latin America. For more information about Exactech, visit http://www.exac.com.
Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
An investment profile on Exactech may be found at http://www.hawkassociates.com/exacprofile.aspx.
Investors may contact Chief Financial Officer Jody Phillips at 352-377-1140 or Julie Marshall and Frank Hawkins, Hawk Associates Inc., at 305-451-1888, e-mail: info@hawkassociates.com. To receive notification of future releases via e-mail alerts, sign up at http://www.hawkassociates.com/email.aspx.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
